The rationale to test IL-24 for its anti-metastatic activity arose from the clinical observation made by Ellerhorst et al. who showed inverse correlation between IL-24 expression, tumor cell invasiveness and disease progression in melanoma [20]. Here, IL24 is linked to melanoma.